Capillary gas chromatographic method for the measurement of small concentrations of monoethylglycinexylidide and lidocaine in plasma.
The major metabolite of lidocaine, monoethylglycinexylidide (MEGX) is currently used as a dynamic marker of liver function. It has been proven, in recent advances, that the determination of MEGX formation after intravenous injection of lidocaine was an effective means of assessing liver dysfunction in critically ill patients. An accurate and sensitive gas chromatographic method has been developed for the determination of small quantities of MEGX formed in such cases. The procedure involves a solid-phase extraction and injection of the extract (splitless mode) into a gas chromatograph equipped with a capillary column and nitrogen-phosphorus detector. The limit of detection is 1 ng/ml and the limit of quantification is 2.5 ng/ml. The response is linear up to 50 ng/ml. The inter- and intra-assay coefficients of variation for MEGX and lidocaine are between 5 and 9%. This method can be used for the determination of small concentrations of MEGX in plasma and could be applied to analysis of small amounts of many other nitrogenous molecules.
Laroche
N
N
Laboratory of Toxicology and Pharmacokinetics, Ambroise Paré Hospital, Boulogne-Billancourt, France.
Leneveu
A
A
Roux
A
A
Flouvat
B
B
D002849:Chromatography, Gas / Q000379:methods*; D006801:Humans; D008012:Lidocaine / Q000031:analogs & derivatives* / Q000097:blood* / Q000493:pharmacokinetics; D008099:Liver / Q000378:metabolism; D008103:Liver Cirrhosis / Q000097:blood; D008111:Liver Function Tests; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
D008012:Lidocaine; C001173:monoethylglycinexylidide